Accenture officer proposes $2.7M share sale

Atsushi Egawa, an Officer of Accenture plc, filed a notice for the proposed sale of 10,000 Class A ordinary shares through UBS Financial Services Inc. The notice lists an aggregate market value of $2,700,000 and an approximate sale date of November 5, 2026.

Available on EDGAR 11/05/2026 - 04:03 PM EST Accepted by SEC EDGAR 11/05/2026 - 04:02 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Atsushi Egawa, an Officer of Accenture plc, filed a notice for the proposed sale of 10,000 Class A ordinary shares through UBS Financial Services Inc. The notice lists an aggregate market value of $2,700,000 and an approximate sale date of November 5, 2026. The shares listed for sale were acquired from the issuer as stock awards.

Key Figures

Shares proposed for sale: 10,000 shares Aggregate market value: $2,700,000 Shares outstanding: 668,722,814 shares

3 metrics

Shares proposed for sale 10,000 shares Class A ordinary shares

Aggregate market value $2,700,000 Securities listed for sale

Shares outstanding 668,722,814 shares Issuer shares outstanding reported in the notice

Key Terms

Rule 144, Aggregate market value, Stock Award, Class A Ordinary

4 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Stock Award financial

"Stock Award | Issuer"

Class A Ordinary financial

"Class A Ordinary"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ACN shares does Atsushi Egawa plan to sell?

Atsushi Egawa’s notice covers 10,000 Class A ordinary shares, with an aggregate market value of $2,700,000 and an approximate sale date of November 5, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002030841
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Accenture plc
SEC File Number	001-34448
Address of Issuer	1 GRAND CANAL SQUARE GRAND CANAL HARBOUR DUBLIN IRELAND D2
Phone	353-1-646-2000
Name of Person for Whose Account the Securities are To Be Sold	Egawa Atsushi
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Ordinary	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	10000	2700000.00	668722814	11/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Ordinary	09/01/2025	Stock Award	Issuer			3673	09/01/2025	N/A
Class A Ordinary	10/15/2024	Stock Award	Issuer			717	10/15/2025	N/A
Class A Ordianry	10/20/2025	Stock Award	Issuer			3863	10/20/2025	N/A
Class A Ordinary	11/14/2025	Stock Award	Issuer			26	11/14/2025	N/A
Class A Ordianry	11/15/2024	Stock Award	Issuer			14	11/15/2024	N/A
Class A Ordinary	02/01/2025	Stock Award	Issuer			1700	02/01/2025	N/A
Class A Ordianry	02/14/2025	Stock Award	Issuer			7	02/14/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	01/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Atsushi Egawa
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)